Sign in

CIK 0001178670

  • Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770602661
Phone
+1 617-551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Planned sale EVP Chief R&D sold 4,713 shares at an average $323.53 ($1,524,796)
  3. 4 Open-market sale Chief Executive Officer sold 2,933 shares at an average $323.08 ($947,581)
  4. 4 Open-market sale EVP, Chief Financial Officer sold 2,468 shares at an average $323.08 ($797,351)
  5. 4 Open-market sale EVP, Chief Commercial Officer sold 2,309 shares at an average $323.08 ($745,984)
  6. 4 Planned sale CSO & EVP, Head of Research sold 1,291 shares at an average $323.54 ($417,685)
  7. 4 Open-market sale EVP, Chief Financial Officer sold 2,206 shares at an average $327.65 ($722,801)
  8. 4 Planned sale EVP Chief R&D sold 3,492 shares at an average $323.63 ($1,130,131)
  9. 4 Planned sale CSO & EVP, Head of Research sold 3,250 shares at an average $323.62 ($1,051,773)
  10. 4 Open-market sale EVP, Chief Commercial Officer sold 1,598 shares at an average $327.65 ($523,584)
  11. 4 Grant or award EVP, CLO and Secretary acquired 1,539 shares (grant or award)
  12. 4 Open-market sale Chief Executive Officer sold 6,799 shares at an average $327.65 ($2,227,698)
  13. 4 Exercise or conversion Chief Executive Officer acquired 5,921 shares (option exercise)
  14. 4 Exercise or conversion EVP, Chief Financial Officer acquired 1,908 shares (option exercise)
  15. 4 Exercise or conversion EVP, Chief Commercial Officer acquired 1,666 shares (option exercise)
  16. 4 Planned sale EVP Chief R&D sold 4,627 shares at an average $331.34 ($1,533,100)
  17. 4 Grant or award CSO & EVP, Head of Research acquired 158 shares (grant or award)
  18. 4 Open-market sale EVP Chief R&D sold 2,242 shares at $310.08 ($695,201)
  19. 4 Open-market sale Chief Executive Officer sold 6,958 shares at $310.08 ($2,157,542)
  20. 4 Open-market sale EVP, Chief Commercial Officer sold 1,959 shares at $310.08 ($607,448)

Page 2 of 47 · 936 filings